Who is sponsoring NCT05588596?

NCT05588596 is sponsored by Central South University.

What drugs are being tested in NCT05588596?

Interventions in NCT05588596: Trauma Resiliency Mindfulness-Informed Intervention.

What condition does NCT05588596 study?

NCT05588596 studies HIV, AIDS, Mindfulness-based Stress Reduction, China, Resilience, PTSD.

Is NCT05588596 still recruiting?

NCT05588596 is currently completed. Last updated 20 October 2022.

Last reviewed 2022-10-20 · How we verify

NCT05588596

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention Program to Address PTSD in People Living With HIV

Completed NA Last updated 20 October 2022

What this trial tests

NA trial testing Trauma Resiliency Mindfulness-Informed Intervention in HIV in 82 participants. Completed in 30 March 2021.

Timeline

3 May 2020

Primary endpoint
30 January 2021

30 March 2021

Quick facts

Lead sponsor	Central South University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	82
Start date	3 May 2020
Primary completion	30 January 2021
Estimated completion	30 March 2021
Sites	1 location across China

Drugs / interventions tested

Trauma Resiliency Mindfulness-Informed Intervention

Conditions studied

HIV — all drugs for HIV →
AIDS — all drugs for AIDS →
Mindfulness-based Stress Reduction — all drugs for Mindfulness-based Stress Reduction →
China — all drugs for China →

Sponsor

Central South University

Who can join

18 and older, any sex, with HIV or AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomised controlled trial is to evaluate the efficacy of an integrated intervention program on post-traumatic stress disorder (PTSD) symptoms and related physiological and psychological indicators of people living with HIV (PLWH). The main question it aims to answer are: * to evaluate the efficacy of the intervention program on PTSD symptoms and related physiological and psychological indicators of PLWH through empirical research. * to analyze the mechanism of the intervention. Eligible PLWH were recruited and randomly divided as intervention group and control group. The efficacy of Trauma Resiliency Mindfulness-Informed Intervention on PTSD symptoms and related physiological and psychological indicators in PLWH was evaluated at baseline, after intervention, and 3 months after intervention through this randomized controlled trial. Researchers compared the intervention group and control group to see if it was feasible and had potential clinical value to introduce the Trauma Resiliency Mindfulness-Informed intervention program into the management of PLWH in China.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The efficacy and mechanism of an integrated mindfulness-based programme on posttraumatic stress disorder among people with HIV: a randomized controlled trial with 3-month follow up.
Tang C, Zhao T, Yu S, Jin Y, et al · · 2026 · PMID 41552987 · DOI 10.1080/20008066.2025.2602298

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other Central South University trials

Trials by the same sponsor.

NCT07444463 — Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications · NA · not yet recruiting
NCT07446478 — TIS for Improving Cognitive Impairment Associated With Schizophrenia · NA · not yet recruiting
NCT07045142 — Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients · Phase 3 · recruiting
NCT07066813 — Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces · recruiting
NCT07063901 — Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05588596 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central South University
Last refreshed: 20 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05588596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing